Ratings by RBC Capital (Ryan Halsted)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/24/2026 | Medpace | MEDP | Maintain | Outperform (N/A) |
|
Details | ||
| 4/23/2026 | Healthcare Services Group | HCSG | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/13/2026 | Charles River Labs | CRL | New Coverage | Outperform (N/A) |
175.65 (218.70) |
24.51% | Details | |
| 3/3/2026 | Medpace | MEDP | New Coverage | Outperform (N/A) |
451.76 (528.12) |
16.9% | Details | |
| 3/3/2026 | Healthcare Services Group | HCSG | New Coverage | Sector Perform (N/A) |
21.77 (23.56) |
8.22% | Details | |
| 3/3/2026 | IQVIA Holdings | IQV | New Coverage | Outperform (N/A) |
178.81 (198.52) |
11.02% | Details | |
| 2/26/2026 | Medline Inc | MDLN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/25/2026 | Evolent Health | EVH | Maintain | (N/A) |
|
Details | ||
| 1/12/2026 | Medline Inc | MDLN | New Coverage | Outperform (N/A) |
41.25 (37.18) |
-9.87% | Details |
